Company intelligence / Profile preview
Enikam
Sloveniaenikam.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Enikam develops and markets innovative cosmetic and pharmaceutical products based on stabilized active oxygen compounds. Their products are designed to support the health of skin, nails, and the oral cavity by promoting cell nourishment and regeneration. The company claims a novel mechanism of action distinct from antibiotics or corticosteroids. Clinical results are not detailed publicly.
- Therapeutic areas
- DermatologyOther
- Modalities
- Small moleculeBiologic (active oxygen compounds)
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Enikam.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Enikam.